Herb Profile

Noni

Morinda citrifolia

Noni (Morinda citrifolia) carries a Grade C rating — limited evidence.

Last reviewed: •3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution — Immune active potential; use caution with autoimmune disease, transplant medicines, immunosuppressants, and during active cancer treatment unless clinician supervised. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Antioxidant, Stress resilience, Inflammatory signaling
Avoid / review if
Liver Disease, Kidney Disease/Hyperkalemia Risk, Pregnancy/Breastfeeding Without Guidance
Next steps

Continue reading

Noni monograph visual
Generated profile category visual

Safety

Safety & Cautions

Immune active potential; use caution with autoimmune disease, transplant medicines, immunosuppressants, and during active cancer treatment unless clinician supervised.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Liver Disease
  • Kidney Disease/Hyperkalemia Risk
  • Pregnancy/Breastfeeding Without Guidance
  • Caution With Potassium Sparing Diuretics
  • ACE Inhibitors/ARBs
  • Anticoagulants
  • And Hepatotoxic Drugs.

Safety classifications

  • Liver-Sensitive: Liver-related caution language appears in the profile.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Immune active potential; use caution with autoimmune disease, transplant medicines, immunosuppressants, and during active cancer treatment unless clinician supervised.

Safety labels

  • Liver-Sensitive
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Bleeding / anticoagulant riskCertainty: Theoretical

Data provenance recorded for 147 of 147 pairings in this mechanism group.

+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Oxidative Stress Modulation · Immune Signaling Modulation

Research maturity: Emerging research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — Immune active potential; use caution with autoimmune disease, transplant medicines, immunosuppressants, and during active cancer treatment unless clinician supervised.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Narrative review
Risk of Bias
High
Consistency
Not assessed
Strongest recorded design is a narrative review, drawn from 3 recorded studies, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (4)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 4 of 4 studies.

What the evidence actually shows

This table contains 4 structured sources, including 1 human evidence source; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Published case reports describe acute hepatitis temporally associated with noni products. The signal is low-incidence/uncertain-causality but clinically relevant enough to retain a liver caution.

Background
Case report

Describes one person or a very small series and can identify signals, but cannot establish typical effects or causality.

—————Published case reports describe acute hepatitis temporally associated with noni products. The signal is low-incidence/uncertain-causality but clinically relevant enough to retain a liver caution.PubMed →

Noni

PubMed indexed authors · 2012

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

Karim G et al. · touchREV Endocrinol · 2023

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Noni Franklin-Tong

Franklin-Tong N et al. · Curr Biol · 2026

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

——————PubMed →

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Fruit juice and require source backed dosage review before therapeutic claims.
How Noni works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Noni Works

How Noni WorksNoni acts on biological target pathways via anti inflammatory, leading to antioxidant efct.NoniBiological TargetBiological pathwayAnti InflammatoryAntioxidant EfctCell protectionAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Inflammatory Signaling Modulation
  • Oxidative Stress Modulation
  • Immune Signaling Modulation

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Noni

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

By Willie B. Randolph III

Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Noni research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs librarySafety checker →